These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30815357)

  • 1. Chinese herbal medicine Qing-Dai-induced pulmonary arterial hypertension in a patient with ulcerative colitis: A case report and experimental investigation.
    Sato K; Ohira H; Horinouchi T; Nakaya T; Mazaki Y; Sugimoto A; Watanabe T; Tsujino I; Nishimura M
    Respir Med Case Rep; 2019; 26():265-269. PubMed ID: 30815357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.
    Kubota K; Imai Y; Okuyama T; Ishiyama Y; Ueno S; Kario K
    Int Heart J; 2023; 64(2):316-320. PubMed ID: 37005323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).
    Misumi K; Ogo T; Ueda J; Tsuji A; Fukui S; Konagai N; Asano R; Yasuda S
    Intern Med; 2019 Feb; 58(3):395-399. PubMed ID: 30210129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pulmonary arterial hypertension following long-term Qing-Dai use for ulcerative colitis.
    Inoue Y; Ishihara A; Mori T; Horio S; Yoshizane T; Arai M; Noda T
    J Cardiol Cases; 2023 May; 27(5):218-221. PubMed ID: 37180221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases.
    Kondo S; Araki T; Okita Y; Yamamoto A; Hamada Y; Katsurahara M; Horiki N; Nakamura M; Shimoyama T; Yamamoto T; Takei Y; Kusunoki M
    Clin J Gastroenterol; 2018 Aug; 11(4):268-272. PubMed ID: 29549501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qing-Dai for pediatric ulcerative colitis multicenter survey and systematic review.
    Kudo T; Jimbo K; Shimizu H; Iwama I; Ishige T; Mizuochi T; Arai K; Kumagai H; Uchida K; Abukawa D; Shimizu T
    Pediatr Int; 2022 Jan; 64(1):e15113. PubMed ID: 35831249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.
    Suzuki H; Kaneko T; Mizokami Y; Narasaka T; Endo S; Matsui H; Yanaka A; Hirayama A; Hyodo I
    World J Gastroenterol; 2013 May; 19(17):2718-22. PubMed ID: 23674882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study.
    Sugimoto S; Naganuma M; Kiyohara H; Arai M; Ono K; Mori K; Saigusa K; Nanki K; Takeshita K; Takeshita T; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hisamatsu T; Inoue N; Ogata H; Iwao Y; Kanai T
    Digestion; 2016; 93(3):193-201. PubMed ID: 26959688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Oral Qing-Dai Medication on Pulmonary Arterial Pressure Levels in Patients With Ulcerative Colitis.
    Orihara Y; Asakura M; Hida N; Kawai M; Sato T; Nishimura K; Masai K; Matsumoto Y; Okuhara Y; Goda A; Masuyama T; Nakamura S; Ishihara M
    Circ J; 2020 Jul; 84(8):1339-1345. PubMed ID: 32595175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preventive effect of Qing Dai on bisphosphonate-induced gastric cellular injuries.
    Yasuda G; Ito H; Kurokawa H; Terasaki M; Suzuki H; Mizokami Y; Matsui H
    J Clin Biochem Nutr; 2019 Jan; 64(1):45-51. PubMed ID: 30705511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qing Dai attenuates nonsteroidal anti-inflammatory drug-induced mitochondrial reactive oxygen species in gastrointestinal epithelial cells.
    Saito R; Tamura M; Matsui H; Nagano Y; Suzuki H; Kaneko T; Mizokami Y; Hyodo I
    J Clin Biochem Nutr; 2015 Jan; 56(1):8-14. PubMed ID: 25678747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anti-colitis activities of Qing Dai/Indigo Naturalis constituents in mice.
    Ozawa K; Mori D; Hatanaka A; Sawano T; Nakatani J; Ikeya Y; Nishizawa M; Tanaka H
    J Pharmacol Sci; 2020 Apr; 142(4):148-156. PubMed ID: 32033881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17A inhibitions of indole alkaloids from traditional Chinese medicine Qing Dai.
    Lee CL; Wang CM; Kuo YH; Yen HR; Song YC; Chou YL; Chen CJ
    J Ethnopharmacol; 2020 Jun; 255():112772. PubMed ID: 32194230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter by Frumkin Regarding Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.".
    Frumkin LR
    Int Heart J; 2023 Nov; 64(6):1166. PubMed ID: 37967984
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to the Letter by Frumkin Regarding the Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis".
    Kubota K; Imai Y; Okuyama T; Ishiyama Y; Ueno S; Kario K
    Int Heart J; 2023; 64(6):1167. PubMed ID: 38030296
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
    Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
    Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Pulmonary Arterial Hypertension During Qing-Dai Use for the Treatment of Ulcerative Colitis.
    Adachi S; Nakano Y; Kondo T
    Circ J; 2020 Jul; 84(8):1235-1236. PubMed ID: 32655110
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey.
    Naganuma M; Sugimoto S; Suzuki H; Matsuno Y; Araki T; Shimizu H; Hayashi R; Fukuda T; Nakamoto N; Iijima H; Nakamura S; Kataoka M; Tamura Y; Tatsumi K; Hibi T; Suzuki Y; Kanai T;
    J Gastroenterol; 2019 Oct; 54(10):891-896. PubMed ID: 31102012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole alkaloids indigodoles A-C from aerial parts of Strobilanthes cusia in the traditional Chinese medicine Qing Dai have anti-IL-17 properties.
    Lee CL; Wang CM; Hu HC; Yen HR; Song YC; Yu SJ; Chen CJ; Li WC; Wu YC
    Phytochemistry; 2019 Jun; 162():39-46. PubMed ID: 30852259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice.
    Xiao HT; Peng J; Hu DD; Lin CY; Du B; Tsang SW; Lin ZS; Zhang XJ; Lueng FP; Han QB; Bian ZX
    Chin Med; 2015; 10():29. PubMed ID: 26464580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.